GLI1 and pituitary tumor: Since ACTH-, GH- and PRL-immunopositive PitNETs show the highest SHH and GLI1 levels, we propose that HH signaling activity may play a role in formation and/or maintenance of these pituitary tumor subtypes (11) as it is known for classical HH-associated tumors.